Want to join the conversation?
Fertilizer maker $CF reported a drop in 2Q16 earnings due to lower sales. Net income fell to $47MM or $0.20 per share from $352MM or $1.49 per share last year. Net sales declined to $1.13Bil from $1.31Bil, due to lower average selling prices across all segments. Adjusted EPS dropped to $0.33 from $1.61.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.